Protein kinases as drug targets in human and animal diseases

Suvarna G. Kini, Vikas Garg, Sarada Prasanna, Revathi Rajappan, Muhammad Mubeen

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)


Almost thirty percent of the protein targets currently under exploration and study constitute the protein kinases which have always attracted the pharmaceutical companies as they are easy targets for drug development. Although the kinases will remain major focus of oncology for many years to come in the development of anticancer drugs, the number of kinase inhibitors as therapeutic targets for the treatment of several other diseases which are undergoing clinical trials are exponentially increasin. In this review, we discuss very briefly the different types of protein kinases that have been used as targets for developing drugs for cancer, inflammation, autoimmune disease, heart disease andanimal diseases.

Original languageEnglish
Pages (from-to)99-106
Number of pages8
JournalCurrent Enzyme Inhibition
Issue number2
Publication statusPublished - 01-08-2017

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Drug Discovery


Dive into the research topics of 'Protein kinases as drug targets in human and animal diseases'. Together they form a unique fingerprint.

Cite this